The acquisition, which will give Sanofi a combination vaccine for respiratory syncytial virus and human metapneumovirus, ...

Sanofi SA (NASDAQ:SNY) on Tuesday agreed to acquire Vicebio Ltd, a privately held biotechnology company headquartered in ...

AI has become a critical tool in diagnosing and managing viral infections such as influenza, respiratory syncytial virus (RSV ...

Study shows key role for human T cells in the control of Respiratory Syncytial Virus (RSV) infection Date: May 24, 2023 Source: University of North Carolina Health Care Summary: A new study has ...

WHAT WE FOUND Human Metapneumovirus (HMPV) is not new. The respiratory virus was first identified in 2001, according to the Centers for Disease Control and Prevention.

The US Food and Drug Administration’s independent vaccine advisers voted Thursday in favor of recommending approval of a new vaccine to protect infants from respiratory syncytial virus, known as ...

Research focuses on the design of a multi-epitope polyvalent vaccine against Human Respiratory Syncytial Virus (RSV), a leading cause of lower respiratory tract infections. The study utilizes ...

It's called human metapneumovirus (HMPV). "The symptoms are identical almost to influenza and respiratory syncytial virus," said Dr. Jorge Rodriguez, a board-certified internal medicine specialist.

Yes, folks, 2023 saw yet another case of a respiratory virus surging beyond what it normally does. The influenza and respiratory syncytial viruses spiked much higher this winter than in previous ...

It is a seasonal disease that usually occur s in the winter and early spring, similar to Respiratory Syncytial Virus (RSV) and the flu. In the US, HMPV circulates in distinct annual seasons.

But hMPV, which causes respiratory tract infections similar to colds and flu, is not new in China or elsewhere in the world and, as of Jan. 9, Chinese officials have not declared any emergency ...